Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repligen Co. (NASDAQ:RGEN – Get Rating)’s stock price shot up 4.5% during mid-day trading on Monday . The company traded as high as $167.87 and last traded at $167.40. 133,416 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 571,400 shares. The stock had previously closed at $160.25. […]
Bank of New York Mellon Corp cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 2.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 983,641 shares of the biotechnology company’s stock after selling 23,204 shares during the quarter. Bank of New York Mellon Corp’s holdings in Repligen were worth $184,049,000 […]
Repligen Co. (NASDAQ:RGEN – Get Rating) – Jefferies Financial Group decreased their Q1 2023 EPS estimates for Repligen in a report issued on Wednesday, November 2nd. Jefferies Financial Group analyst B. Couillard now anticipates that the biotechnology company will post earnings per share of $0.70 for the quarter, down from their prior forecast of $0.89. […]
US Bancorp DE boosted its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 28.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,890 shares of the biotechnology company’s stock after purchasing an additional 5,085 shares during the quarter. US Bancorp DE’s holdings […]
Repligen Co. (NASDAQ:RGEN – Get Rating) – Equities research analysts at SVB Leerink dropped their Q1 2023 earnings per share estimates for Repligen in a research report issued on Wednesday, October 19th. SVB Leerink analyst P. Souda now anticipates that the biotechnology company will post earnings of $0.81 per share for the quarter, down from […]